首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Digital biomarkers

缩写:

ISSN:2504-110X

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引166
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yasin Ozkanca,Miraç Göksu Öztürk,Merve Nur Ekmekci et al. Yasin Ozkanca et al.
Depression is a common mental health problem leading to significant disability world wide. Depression is not only common but also commonly co-occurs with other mental and neurological illnesses. Parkinson's Disease gives rise to symptoms di...
Amy R Sheon,Brian Van Winkle,Yauheni Solad et al. Amy R Sheon et al.
Over the last several years, there has been rapid growth of digital technologies attempting to transform healthcare. Unique features of digital medicine technology lead to both challenges and opportunities for testing and validation. Yet li...
Justin M Wright,Graham B Jones Justin M Wright
The increasing availability of devices capable of tracking biomarkers presents major opportunities in contemporary healthcare. Herein we advocate a new role for the pharmaceutical industry to capitalize on these opportunities and in doing s...
Brian Perry,Will Herrington,Jennifer C Goldsack et al. Brian Perry et al.
Background: The use of mobile devices in clinical research has advanced substantially in recent years due to the rapid pace of technology development. With an overall aim of informing the future use of mobile devices in i...
Dustin A Heldman,Denzil A Harris,Timothy Felong et al. Dustin A Heldman et al.
Background: Parkinson's disease (PD) motor symptoms can fluctuate and may not be accurately reflected during a clinical evaluation. In addition, access to movement disorder specialists is limited for many with PD. The obj...
John Torous,Jorge Rodriguez,Adam Powell John Torous
As smartphone and sensors continue to become more ubiquitous across the world, digital biomarkers have emerged as a scalable and practical tool to explore disease states and advance health. But as the digital divide of access and ownership ...